We are live on ! Find out more
T

TCWP Portfolio holdings

AUM $40.8M
1-Year Est. Return 31.25%
This Fund
S&P 500
This Quarter Est. Return
-11.55%
1 Year Est. Return
+31.25%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$470M
AUM Growth
-$80.2M
Cap. Flow
-$17.9M
Cap. Flow %
-3.8%
Top 10 Hldgs %
29.92%
Holding
1,989
New
13
Increased
141
Reduced
104
Closed
1,723

Top Buys

Rank Stock Value
1
EELV icon
Invesco S&P Emerging Markets Low Volatility ETF
EELV
+$6.67M
2
RNR icon
RenaissanceRe
RNR
+$6.18M
3
PINC
Premier
PINC
+$6M
4
CHKP icon
Check Point Software Technologies
CHKP
+$5.95M
5
EQC
Equity Commonwealth
EQC
+$5.91M

Top Sells

Rank Stock Value
1
IVW icon
iShares S&P 500 Growth ETF
IVW
+$7.08M
2
FMC icon
FMC
FMC
+$6.75M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.25M
4
AMGN icon
Amgen
AMGN
+$6.13M
5
SJM icon
J.M. Smucker
SJM
+$5.71M

Sector Composition

Rank Sector Weight
1 Technology 7.35%
2 Healthcare 6.08%
3 Financials 5.78%
4 Consumer Staples 3.4%
5 Materials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTAP icon
1226
NetApp
NTAP
$32.3B
– –
-54
Closed -$4K
NTES icon
1227
NetEase
NTES
$76.9B
– –
-26
Closed -$2K
NTLA icon
1228
Intellia Therapeutics
NTLA
$1.55B
– –
-40
Closed -$2K
NTNX icon
1229
Nutanix
NTNX
$14.2B
– –
-64
Closed -$1K
NTRA icon
1230
Natera
NTRA
$37.9B
– –
-55
Closed -$2K
NTRS icon
1231
Northern Trust
NTRS
$21.9B
– –
-143
Closed -$16K
NUMG icon
1232
Nuveen ESG Mid-Cap Growth ETF
NUMG
$344M
– –
-13
Closed –
NUS icon
1233
Nu Skin
NUS
$247M
– –
-24
Closed -$1K
NUSC icon
1234
Nuveen ESG Small-Cap ETF
NUSC
$1.28B
– –
-98
Closed -$3K
NVAX icon
1235
Novavax
NVAX
$1.29B
– –
-11
Closed –
NVCR icon
1236
NovoCure
NVCR
$2.32B
– –
-147
Closed -$12K
NVEC icon
1237
NVE Corp
NVEC
$649M
– –
-3
Closed –
NVG icon
1238
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.66B
– –
-950
Closed -$14K
NVMI
1239
Nova
NVMI
$14.5B
– –
-40
Closed -$4K
NVO
1240
Novo Nordisk
NVO
$213B
– –
-886
Closed -$49K
NVRI icon
1241
Enviri
NVRI
$633M
– –
-137
Closed -$1K
NVS icon
1242
Novartis
NVS
$297B
– –
-1,211
Closed -$106K
NVST icon
1243
Envista
NVST
$4.26B
– –
-52
Closed -$2K
NVTS icon
1244
Navitas Semiconductor
NVTS
$2.93B
– –
-100
Closed -$1K
NWG icon
1245
NatWest
NWG
$71B
– –
-1,025
Closed -$6K
NWL icon
1246
Newell Brands
NWL
$2.14B
– –
-1,237
Closed -$26K
NWN icon
1247
Northwest Natural Holdings
NWN
$2.16B
– –
-23
Closed -$1K
NWPX icon
1248
NWPX Infrastructure Inc
NWPX
$1.28B
– –
-44
Closed -$1K
NWSA icon
1249
News Corp Class A
NWSA
$14.3B
– –
-102
Closed -$2K
NXPI icon
1250
NXP Semiconductors
NXPI
$70B
– –
-433
Closed -$80K
48 49
50
51 52

Similar funds

KLC
Knowledge Leaders Capital Denver, Colorado $42.2M AUM 24.52% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
DLPIC
Davide Leone & Partners Investment Company London, United Kingdom $49M AUM 43.06% 1-Year Est. Return
CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
EL
Envoi LLC Chanhassen, Minnesota $31.5M AUM 0.03% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
DC
Dryden Capital Miami, Florida $58.9M AUM 8.83% 1-Year Est. Return
SP
Systematic Portfolios New York $14.4M AUM

TCWP's Q2 2022 Portfolio in Review

As of Q2 2022, TCWP held 1,989 positions worth $470M, down 15% from $550M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

TCWP withdrew a net $17.9M in Q2 2022, closing 1,723 positions and reducing 104 holdings. Its most notable exit was iShares S&P 500 Growth ETF, an estimated $7.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 7.2% a quarter earlier, followed by Healthcare and Financials.

Against the trend, TCWP opened a new position in Invesco S&P Emerging Markets Low Volatility ETF worth $6.25M.

  • TCWP's largest Q2 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 268,959 shares worth $6.25M.
  • TCWP added most to RenaissanceRe in Q2 2022, an estimated $6.18M increase.
  • TCWP's biggest Q2 2022 reduction was Amgen, cutting an estimated $6.13M.
  • TCWP fully exited iShares S&P 500 Growth ETF in Q2 2022, selling an estimated $7.08M.
  • TCWP's ten largest holdings make up 30% of its $470M portfolio in Q2 2022.
  • TCWP opened 13 new positions and closed 1,723 in Q2 2022.
  • TCWP's portfolio value fell 15% quarter-over-quarter to $470M.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.